About Tr1XTr1X is a private clinical-stage biotechnology company focused on developing a novel class of regulatory T cell-based products to cure autoimmune and inflammatory diseases. Founded by industry experts including the scientists who discovered Type 1 regulatory T (Tr1) cells th
More...